First time intravesically administered trifunctional antibody catumaxomab in patients with recurrent non-muscle invasive bladder cancer indicates high tolerability and local immuno...

por Ruf, Peter, Bauer, Hartwig W., Schoberth, Alexandra, Kellermann, Claudia, Lindhofer, Horst
Publicado 2021